From Proteopedia
(Difference between revisions)
proteopedia linkproteopedia link
|
|
Line 1: |
Line 1: |
- | [[Image:1f0r.gif|left|200px]] | + | {{Seed}} |
| + | [[Image:1f0r.png|left|200px]] |
| | | |
| <!-- | | <!-- |
Line 9: |
Line 10: |
| {{STRUCTURE_1f0r| PDB=1f0r | SCENE= }} | | {{STRUCTURE_1f0r| PDB=1f0r | SCENE= }} |
| | | |
- | '''CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815'''
| + | ===CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815=== |
| | | |
| | | |
- | ==Overview==
| + | <!-- |
- | Involved in the coagulation cascade, factor Xa (FXa) is a serine protease which has received great interest as a potential target for the development of new antithrombotics. Although there is a great wealth of structural data on thrombin complexes, few structures of ligand/FXa complexes have been reported, presumably because of the difficulty in growing crystals. Reproducible crystallization conditions for human des-Gla1-45 coagulation FXa have been found. This has led to an improvement in the diffraction quality of the crystals (about 2.1 A) when compared to the previously reported forms (2.3-2.8 A) thus providing a suitable platform for a structure-based drug design approach. A series of crystal structures of noncovalent inhibitors complexed with FXa have been determined, three of which are presented herein. These include compounds containing the benzamidine moiety and surrogates of the basic group. The benzamidine-containing compound binds in a canonical fashion typical of synthetic serine protease inhibitors. On the contrary, molecules that contain surrogates of the benzamidine group do not make direct hydrogen-bonding interactions with the carboxylate of Asp189 at the bottom of the S1 pocket. The structural data provide a likely explanation for the specificity of these inhibitors and a great aid in the design of bioavailable potent FXa inhibitors.
| + | The line below this paragraph, {{ABSTRACT_PUBMED_10966741}}, adds the Publication Abstract to the page |
| + | (as it appears on PubMed at http://www.pubmed.gov), where 10966741 is the PubMed ID number. |
| + | --> |
| + | {{ABSTRACT_PUBMED_10966741}} |
| | | |
| ==About this Structure== | | ==About this Structure== |
Line 34: |
Line 38: |
| [[Category: Spada, A P.]] | | [[Category: Spada, A P.]] |
| [[Category: Protein-inhibitor complex]] | | [[Category: Protein-inhibitor complex]] |
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 15:45:14 2008'' | + | |
| + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 1 02:18:36 2008'' |
Revision as of 23:18, 30 June 2008
Template:STRUCTURE 1f0r
CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815
Template:ABSTRACT PUBMED 10966741
About this Structure
1F0R is a Protein complex structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.
Reference
Crystal structures of human factor Xa complexed with potent inhibitors., Maignan S, Guilloteau JP, Pouzieux S, Choi-Sledeski YM, Becker MR, Klein SI, Ewing WR, Pauls HW, Spada AP, Mikol V, J Med Chem. 2000 Aug 24;43(17):3226-32. PMID:10966741
Page seeded by OCA on Tue Jul 1 02:18:36 2008
Categories: Coagulation factor Xa | Homo sapiens | Protein complex | Becker, M R. | Choi-Sledeski, Y M. | Ewing, W R. | Guilloteau, J P. | Klein, S I. | Maignan, S. | Mikol, V. | Pauls, H W. | Pouzieux, S. | Spada, A P. | Protein-inhibitor complex